Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06327061 · ClinicalTrials.gov registry record · NA

Social Network Overdose Prevention and Education Intervention

A NA study of Drug Overdose, sponsored by Johns Hopkins Bloomberg School of Public Health.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT06327061 is a NA study of Drug Overdose that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 600 participants, above the 362-participant average among 5 other Drug Overdose trials with a reported enrollment target (66% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06327061, a NA study of Drug Overdose, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test a social intervention focused on overdose prevention and care. In the investigators prior work, the investigators have shown that people who use opioids (PWUO) can be effective peer educators (PEs).

Conditions Studied

Interventions

  • BEHAVIORAL Network overdose prevention
  • BEHAVIORAL Standard of care health education

Study Locations (1)

Maryland

  • Johns Hopkins Bloomberg School of Public Health - Baltimore

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2024-06-01
Est. Completion 2029-04-01
Phase NA

What the Registry Record Tells You About NCT06327061

The ClinicalTrials.gov registry entry for NCT06327061 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 362-participant average among 5 other Drug Overdose trials with a reported enrollment target (66% higher). The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Drug Overdose appearing as the primary indexed condition, and to 2 interventions - of which Network overdose prevention is the first listed.

NCT06327061 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06327061 about?

NCT06327061 is a clinical study titled "Social Network Overdose Prevention and Education Intervention". The purpose of this study is to test a social intervention focused on overdose prevention and care. In the investigators prior work, the investigators have shown that people who use opioids (PWUO) can be effective peer educators (PEs).

What is the current status of trial NCT06327061?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-06-01. Estimated completion is 2029-04-01.

What conditions does trial NCT06327061 study?

This clinical trial studies the following conditions: Drug Overdose.

What interventions are being tested in trial NCT06327061?

The interventions under investigation include: Network overdose prevention (BEHAVIORAL), Standard of care health education (BEHAVIORAL).

Who is sponsoring clinical trial NCT06327061?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06327061 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Drug Overdose

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.